Clinical response to antibiotics in indigenous versus non-indigenous children under 5 years old with community-acquired pneumonia in Otavalo, Ecuador

INTRODUCTIONCommunity-acquired pneumonia (CAP) is an important cause of morbidity and mortality worldwide. This study compares the clinical response to antimicrobials between indigenous and non-indigenous Kichwa children under 5 years old with CAP in Otavalo, Ecuador. METHODSAll children with CAP who met the inclusion criteria and were admitted at the San Luis de Otavalo Hospital between March 2017 and June 2018 were evaluated. RESULTSNo significant differences were observed in clinical responses between indigenous and non-indigenous children. CONCLUSIONSThe improved healthcare access of the Otavalo's Kichwa population may have contributed to the observed clinical response to CAP treatment.